Title | Type | SJR | H index | Total Docs. (2003) | Total Docs. (3years) | Total Refs. (2003) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2003) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Reviews in Contemporary Pharmacotherapy | journal | 0.471 Q2 | 18 | 1 | 27 | 209 | 34 | 27 | 0.60 | 209.00 | |
2 | Natural Product Reports | journal | 2.710 Q1 | 211 | 43 | 115 | 6706 | 741 | 113 | 6.77 | 155.95 | |
3 | Critical Reviews in Toxicology | journal | 1.068 Q1 | 129 | 20 | 64 | 2954 | 239 | 64 | 2.54 | 147.70 | |
4 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.693 Q1 | 99 | 18 | 23 | 2152 | 137 | 22 | 3.43 | 119.56 | |
5 | Expert Opinion on Therapeutic Targets | journal | 0.556 Q2 | 106 | 61 | 145 | 6058 | 209 | 142 | 1.67 | 99.31 | |
6 | Clinical Pharmacokinetics | journal | 1.316 Q1 | 184 | 82 | 236 | 7970 | 1235 | 228 | 4.62 | 97.20 | |
7 | Expert Opinion on Emerging Drugs | journal | 0.268 Q3 | 54 | 38 | 73 | 3673 | 57 | 69 | 0.50 | 96.66 | |
8 | Advances in Antiviral Drug Design | book series | 12 | 7 | 0 | 619 | 0 | 0 | 0.00 | 88.43 | ||
9 | American Journal of Respiratory Medicine | journal | 0.140 Q4 | 34 | 42 | 51 | 3646 | 14 | 45 | 0.27 | 86.81 | |
10 | Expert Opinion on Investigational Drugs | journal | 0.971 Q1 | 117 | 153 | 769 | 13274 | 2287 | 745 | 2.99 | 86.76 | |
11 | Toxicological Reviews | journal | 49 | 23 | 0 | 1905 | 0 | 0 | 0.00 | 82.83 | ||
12 | Expert Opinion on Biological Therapy | journal | 0.869 Q1 | 102 | 116 | 176 | 9049 | 509 | 167 | 2.89 | 78.01 | |
13 | Progress in Pharmaceutical and Biomedical Analysis | book series | 0.138 Q3 | 8 | 17 | 49 | 1231 | 15 | 47 | 0.00 | 72.41 | |
14 | Expert Review of Vaccines | journal | 0.190 Q3 | 105 | 78 | 57 | 5374 | 27 | 53 | 0.47 | 68.90 | |
15 | Molecular Diagnosis and Therapy | journal | 68 | 57 | 172 | 3899 | 289 | 159 | 1.82 | 68.40 | ||
16 | Expert Opinion on Pharmacotherapy | journal | 0.541 Q2 | 93 | 204 | 417 | 13857 | 824 | 403 | 1.90 | 67.93 | |
17 | Drug Safety | journal | 0.981 Q1 | 140 | 82 | 257 | 5422 | 1071 | 252 | 3.67 | 66.12 | |
18 | Receptors and Channels | journal | 0.887 Q1 | 44 | 40 | 71 | 2478 | 131 | 67 | 2.00 | 61.95 | |
19 | Expert Opinion on Therapeutic Patents | journal | 0.453 Q2 | 88 | 125 | 408 | 7681 | 547 | 404 | 1.44 | 61.45 | |
20 | BioDrugs | journal | 0.499 Q2 | 79 | 55 | 198 | 3338 | 362 | 187 | 2.74 | 60.69 | |
21 | Current Opinion in Investigational Drugs | journal | 0.579 Q2 | 83 | 178 | 271 | 9705 | 545 | 254 | 2.01 | 54.52 | |
22 | Current Opinion in Drug Discovery and Development | journal | 0.700 Q2 | 85 | 94 | 252 | 4970 | 556 | 238 | 2.34 | 52.87 | |
23 | Neuropsychopharmacology | journal | 2.486 Q1 | 249 | 274 | 538 | 14161 | 3018 | 505 | 5.11 | 51.68 | |
24 | Journal of Drug Evaluation | journal | 5 | 21 | 0 | 1019 | 0 | 0 | 0.00 | 48.52 | ||
25 | Toxin Reviews | journal | 0.227 Q3 | 54 | 43 | 47 | 2070 | 41 | 41 | 0.77 | 48.14 | |
26 | Fundamental and Clinical Pharmacology | journal | 0.367 Q3 | 85 | 76 | 171 | 3587 | 207 | 166 | 1.17 | 47.20 | |
27 | Neuropharmacology | journal | 1.830 Q1 | 191 | 219 | 760 | 10316 | 3065 | 760 | 3.83 | 47.11 | |
28 | Autonomic and Autacoid Pharmacology | journal | 0.306 Q3 | 24 | 34 | 35 | 1482 | 11 | 34 | 0.31 | 43.59 | |
29 | Journal of Peptide Science | journal | 0.584 Q2 | 73 | 74 | 195 | 3189 | 314 | 191 | 1.41 | 43.09 | |
30 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.636 Q2 | 57 | 45 | 120 | 1937 | 163 | 108 | 1.51 | 43.04 | |
31 | PharmacoEconomics | journal | 1.006 Q1 | 118 | 103 | 328 | 4348 | 869 | 317 | 2.53 | 42.21 | |
32 | Toxicology Mechanisms and Methods | journal | 0.152 Q4 | 55 | 35 | 80 | 1447 | 39 | 79 | 0.39 | 41.34 | |
33 | Trends in Pharmacological Sciences | journal | 3.830 Q1 | 244 | 133 | 500 | 5424 | 3154 | 382 | 5.79 | 40.78 | |
34 | Mutagenesis | journal | 0.696 Q2 | 102 | 79 | 236 | 3218 | 425 | 230 | 1.78 | 40.73 | |
35 | Tetrahedron | journal | 1.482 Q1 | 236 | 1067 | 3320 | 43182 | 9119 | 3304 | 2.78 | 40.47 | |
36 | Current Opinion in Molecular Therapeutics | journal | 1.024 Q1 | 67 | 101 | 252 | 4049 | 725 | 232 | 2.95 | 40.09 | |
37 | Toxicological Sciences | journal | 1.116 Q1 | 207 | 277 | 802 | 11064 | 2556 | 775 | 2.97 | 39.94 | |
38 | Antiviral Chemistry and Chemotherapy | journal | 0.532 Q2 | 59 | 34 | 110 | 1342 | 194 | 110 | 1.64 | 39.47 | |
39 | Journal of Veterinary Pharmacology and Therapeutics | journal | 0.465 Q2 | 67 | 61 | 197 | 2388 | 201 | 191 | 0.89 | 39.15 | |
40 | International Journal of Neuropsychopharmacology | journal | 1.127 Q1 | 125 | 58 | 144 | 2265 | 423 | 133 | 3.00 | 39.05 | |
41 | BMC Clinical Pharmacology | journal | 0.336 Q3 | 43 | 4 | 12 | 156 | 16 | 12 | 1.33 | 39.00 | |
42 | Comments on Toxicology | journal | 0.184 Q4 | 13 | 12 | 47 | 466 | 12 | 41 | 0.26 | 38.83 | |
43 | Drug Design and Discovery | journal | 0.582 Q2 | 20 | 12 | 38 | 466 | 45 | 33 | 1.00 | 38.83 | |
44 | Journal of Food Biochemistry | journal | 0.332 Q3 | 64 | 31 | 104 | 1195 | 61 | 104 | 0.61 | 38.55 | |
45 | Food and Chemical Toxicology | journal | 0.688 Q2 | 203 | 188 | 463 | 7121 | 984 | 451 | 2.07 | 37.88 | |
46 | Journal of Applied Toxicology | journal | 0.418 Q2 | 103 | 55 | 278 | 2053 | 353 | 275 | 1.13 | 37.33 | |
47 | Environmental Pollution | journal | 1.562 Q1 | 301 | 281 | 764 | 10366 | 1940 | 743 | 2.30 | 36.89 | |
48 | Inhalation Toxicology | journal | 0.567 Q2 | 97 | 78 | 319 | 2849 | 432 | 312 | 1.49 | 36.53 | |
49 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.029 Q1 | 106 | 44 | 172 | 1601 | 324 | 172 | 1.29 | 36.39 | |
50 | Journal of Toxicology and Environmental Health - Part A: Current Issues | journal | 0.650 Q2 | 99 | 144 | 412 | 5208 | 694 | 406 | 1.74 | 36.17 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®